About Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego – wielospecjalistyczna jednostka opieki zdrowotnej, mieszcząca się przy ul. Borowskiej 213 we Wrocławiu. Organem założycielskim jest Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
21
Pfizer
21
Celgene
19
Hoffmann-La Roche
13
Takeda
8
Bayer
6
Shire
4
Amgen
3
Merck Sharp & Dohme LLC
3
PregLem SA
3
AVEO Pharmaceuticals, Inc.
2
Clinical Trials at Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu
During the past decade, Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu conducted 132 clinical trials. In the 10-year time frame, 132 clinical trials started and 56 clinical trials were completed, i.e. on
average, 42.4% percent of trials that started reached the finish line to date. In the past 5 years, 61 clinical trials started and 33 clinical trials were completed. i.e. 54.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care
2003-11-01
2007-07-01
Completed
358
Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
2006-03-01
2010-07-01
Completed
676
A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD
2007-04-01
2009-10-01
Terminated
158
Placebo Controlled Study of 3 Doses of Rifaximin-EIR Tablet to Treat Moderate, Active Crohn's Disease
2007-09-01
2009-10-01
Completed
410
A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL
2007-09-01
2011-05-01
Terminated
151
A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.
2008-02-04
2017-05-02
Completed
228
Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612)
2007-08-01
2012-01-01
Completed
812
Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%)
2008-06-01
Completed
317
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu" #1 sponsor was "Janssen Research & Development, LLC" with 21 trials, followed by "Pfizer" with 21 trials
sponsored, "Celgene" with 19 trials sponsored, "Hoffmann-La Roche" with 13 trials sponsored and "Takeda"
with 13 trials sponsored. Other sponsors include 88 different institutions and
companies that sponsored additional 71 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu"
#1 collaborator was "AbbVie" with 2 trials as a collaborator, "Baxalta Innovations GmbH, now part of Shire" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "National Center for Research and Development, Poland" with 2 trials as a collaborator. Other collaborators include 24 different institutions and companies that were
collaborators in the rest 32 trials.
Clinical Trials Conditions at Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu
According to Clinical.Site data, the most researched conditions in "Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu" are
"Multiple Myeloma" (9 trials), "Crohn Disease" (7 trials), "Chronic Lymphocytic Leukemia" (5 trials), "Myelodysplastic Syndromes" (5 trials) and "Diffuse Large B-cell Lymphoma" (4 trials). Many other conditions were trialed in "Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu" in a lesser frequency.
Clinical Trials Intervention Types at Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu
Most popular intervention types in "Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu" are "Drug" (150 trials), "Biological" (24 trials), "Other" (22 trials), "Device" (3 trials) and "Combination Product" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (37 trials), "Rituximab" (11 trials), "Lenalidomide" (9 trials), "Dexamethasone" (7 trials) and "Azacitidine" (5 trials). Other intervention names were less common.
Clinical Trials Genders at Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu
The vast majority of trials in "Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu" are
168 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu
Currently, there are 85 active trials in "Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu".
1 are not yet recruiting,
58 are recruiting,
24 are Active, not recruiting,
and 2 are Enrolling by invitation.
In total, there were 72 completed trials in Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu,
undefined suspended trials,
and 14 terminated clinical trials to date.
Out of the total trials that were conducted in Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu, 11 "Phase 1"
clinical trials were conducted, 50 "Phase 2" clinical
trials and 104 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 10 trials, and there were
also 3 trials that are defined as “Not Applicable".